FDA Clearance Tracker · P010018-S009
VIEWPOINT CK SYSTEM
Last checked: Nov 20, 2026Latest source record: Apr 6, 2006 (this decision)Source: openFDAMethods & limitations
Decided
Apr 6, 2006
Approved
Time to decision
87 days
Received Jan 9, 2006. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P010018-S009
- Device name
- VIEWPOINT CK SYSTEM
- Applicant
- Refractec, Inc.
- Applicant location
- Irvine, CA
- Received
- Jan 9, 2006
- Decided
- Apr 6, 2006
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P010018
Device type
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR UPDATING THE LABELING WITH THE 24 MONTH CLINICAL STUDY RESULTS FOR CK TREATMENT TO IMPROVE NEAR VISION IN THE EMMETROPIC AND HYPEROPIC PRESBYOPES.
Source documents
Other decisions for Refractec, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.